A random-effects model was used to account for heterogeneity among the trials
Spectrochim Acta A Mol Biomol Spectrosc
While also not prescribing GLP-1s personally, Brandon Peters, MD, FAASM, a sleep physician at Virginia Mason Medical Center, has patients taking GLP-1s for obesity or diabetes and seeing improvements in their OSA
Snack Greek Yogurt Parfait Simple, delicious, and, best of all, its good for you
MOTS-c and NAD+ work differently but overlap in one key area: MOTS-c increases cellular NAD+ levels as part of its mechanism, which means stacking both compounds can create a synergistic effect rather than a redundant one
IGF-1 LR3 is not approved for therapeutic use in humans and is intended strictly for research purposes